Advanced Medical Isotope Return on Tangible Equity 2013-2024 | RDGL
Current and historical return on tangible equity values for Advanced Medical Isotope (RDGL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Advanced Medical Isotope Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-12-31 |
$0.00B |
$0.00B |
-266.67% |
| 2024-09-30 |
$0.00B |
$0.00B |
-320.00% |
| 2024-06-30 |
$0.00B |
$0.00B |
-320.00% |
| 2024-03-31 |
$0.00B |
$0.00B |
-320.00% |
| 2023-12-31 |
$0.00B |
$0.00B |
-240.00% |
| 2023-09-30 |
$0.00B |
$0.00B |
-200.00% |
| 2023-06-30 |
$0.00B |
$0.00B |
-114.29% |
| 2023-03-31 |
$0.00B |
$0.00B |
-133.33% |
| 2022-12-31 |
$0.00B |
$0.00B |
-200.00% |
| 2022-09-30 |
$0.00B |
$0.00B |
-160.00% |
| 2022-06-30 |
$0.00B |
$0.00B |
-200.00% |
| 2022-03-31 |
$0.00B |
$0.00B |
-240.00% |
| 2021-12-31 |
$0.00B |
$0.00B |
-133.33% |
| 2021-09-30 |
$0.00B |
$0.00B |
-160.00% |
| 2021-06-30 |
$0.00B |
$0.00B |
-266.67% |
| 2021-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2020-12-31 |
$0.00B |
$0.00B |
0.00% |
| 2020-09-30 |
$0.00B |
$0.00B |
100.00% |
| 2020-06-30 |
$0.00B |
$0.00B |
200.00% |
| 2020-03-31 |
$0.00B |
$0.00B |
200.00% |
| 2019-12-31 |
$0.00B |
$0.00B |
200.00% |
| 2019-09-30 |
$0.03B |
$0.00B |
-2500.00% |
| 2019-06-30 |
$0.00B |
$0.00B |
10.53% |
| 2019-03-31 |
$-0.01B |
$0.00B |
58.33% |
| 2018-12-31 |
$-0.01B |
$0.00B |
61.54% |
| 2018-09-30 |
$-0.04B |
$-0.04B |
269.09% |
| 2018-06-30 |
$-0.01B |
$-0.01B |
200.00% |
| 2018-03-31 |
$-0.01B |
$-0.01B |
200.00% |
| 2017-12-31 |
$-0.01B |
$0.00B |
200.00% |
| 2017-09-30 |
$0.00B |
$0.00B |
123.08% |
| 2017-06-30 |
$0.00B |
$0.00B |
61.54% |
| 2017-03-31 |
$0.00B |
$0.00B |
106.67% |
| 2016-12-31 |
$-0.01B |
$0.00B |
153.85% |
| 2016-09-30 |
$-0.01B |
$0.00B |
109.09% |
| 2016-06-30 |
$-0.01B |
$-0.01B |
126.32% |
| 2016-03-31 |
$0.00B |
$-0.01B |
8.16% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-50.00% |
| 2015-09-30 |
$-0.01B |
$-0.01B |
54.55% |
| 2015-06-30 |
$-0.01B |
$-0.02B |
42.42% |
| 2015-03-31 |
$-0.02B |
$-0.02B |
100.00% |
| 2014-12-31 |
$-0.02B |
$-0.02B |
150.00% |
| 2014-09-30 |
$0.00B |
$-0.01B |
43.24% |
| 2014-06-30 |
$0.00B |
$-0.01B |
43.24% |
| 2014-03-31 |
$0.00B |
$-0.01B |
45.71% |
| 2013-12-31 |
$0.00B |
$-0.01B |
45.71% |
| 2013-09-30 |
$-0.01B |
$-0.01B |
77.78% |
| 2013-06-30 |
$-0.01B |
$-0.01B |
118.52% |
| 2013-03-31 |
$-0.01B |
$-0.01B |
168.42% |
| 2012-12-31 |
$-0.01B |
$-0.01B |
320.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
FIN-SBIC&COMMRL |
$0.068B |
$0.000B |
|
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
|
